Skip to main content
. 2021 Jan 27;13:805–814. doi: 10.2147/CMAR.S285909

Figure 2.

Figure 2

Osteosarcoma patients with high miR-183-5p expression (miR-183-5p high, n= 40) had worse overall survival (A) and recurrence-free survival (B) than those with low miR-183-5p expression (miR-183-5p low, n= 40).